Standard
The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation. / Vinding, Naja Emborg; Bonde, Anders Nissen; Rørth, Rasmus; Lamberts, Morten; Olesen, Jonas Bjerring; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian; Køber, Lars; Fosbøl, Emil Loldrup.
I:
Europace, Bind 21, Nr. 4, 2019, s. 572-580.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Vinding, NE, Bonde, AN, Rørth, R
, Lamberts, M, Olesen, JB
, Gislason, GH, Torp-Pedersen, C
, Køber, L & Fosbøl, EL 2019, '
The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation',
Europace, bind 21, nr. 4, s. 572-580.
https://doi.org/10.1093/europace/euy262APA
Vinding, N. E., Bonde, A. N., Rørth, R.
, Lamberts, M., Olesen, J. B.
, Gislason, G. H., Torp-Pedersen, C.
, Køber, L., & Fosbøl, E. L. (2019).
The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
Europace,
21(4), 572-580.
https://doi.org/10.1093/europace/euy262Vancouver
Vinding NE, Bonde AN, Rørth R
, Lamberts M, Olesen JB
, Gislason GH o.a.
The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
Europace. 2019;21(4):572-580.
https://doi.org/10.1093/europace/euy262Author
Vinding, Naja Emborg ; Bonde, Anders Nissen ; Rørth, Rasmus ; Lamberts, Morten ; Olesen, Jonas Bjerring ; Gislason, Gunnar Hilmar ; Torp-Pedersen, Christian ; Køber, Lars ; Fosbøl, Emil Loldrup. / The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation. I: Europace. 2019 ; Bind 21, Nr. 4. s. 572-580.
Bibtex
@article{8d2a577ae68744a7a136ac9cd70b9ec6,
title = "The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation",
author = "Vinding, {Naja Emborg} and Bonde, {Anders Nissen} and Rasmus R{\o}rth and Morten Lamberts and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Christian Torp-Pedersen and Lars K{\o}ber and Fosb{\o}l, {Emil Loldrup}",
year = "2019",
doi = "10.1093/europace/euy262",
language = "English",
volume = "21",
pages = "572--580",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "4",
}
RIS
TY - JOUR
T1 - The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation
AU - Vinding, Naja Emborg
AU - Bonde, Anders Nissen
AU - Rørth, Rasmus
AU - Lamberts, Morten
AU - Olesen, Jonas Bjerring
AU - Gislason, Gunnar Hilmar
AU - Torp-Pedersen, Christian
AU - Køber, Lars
AU - Fosbøl, Emil Loldrup
PY - 2019
Y1 - 2019
U2 - 10.1093/europace/euy262
DO - 10.1093/europace/euy262
M3 - Journal article
C2 - 30508073
VL - 21
SP - 572
EP - 580
JO - Europace
JF - Europace
SN - 1099-5129
IS - 4
ER -
